Shelter Pharma dividend 2025

SHELTER

38

0.00 (0.00%)
Last updated on 23 Dec, 2025 | 09:53 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Shelter Pharma Dividend Details

Record Date

23-Sep-2025

Dividends Date

23-Sep-2025

Ex Date

23-Sep-2025

Dividend Type

Equity Share

Dividend Per Share

3.50

The Shelter Pharma has declared a Equity Share dividend of 3.5 per share. Investors should note the record date of 23-Sep-2025, and the ex-dividend date 23-Sep-2025 to confirm eligibility for the payout. This move underscores the company’s ongoing efforts to enhance shareholder value through regular dividend distributions.

Shelter Pharma Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
23-Sep-20250.04Equity Share23-Sep-2025
01-Jan-00010.03Equity Share23-Sep-2024

Upcoming Dividends by Indian Companies

View More
CompanyDividends RatioAnnouncementRecord DateDividends Date
Prakash Pipes Ltd.0.118-Dec-202524-Dec-202524-Dec-2025

Shelter Pharma Dividend FAQs

The latest dividend declared by Shelter Pharma is of 0.035 per share for the financial year as announced on 23-Sep-2025.

Registered shareholders who own Shelter Pharma’s shares on or before the record date of 23-Sep-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 23-Sep-2025.

You can expect to receive Shelter Pharma’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 23-Sep-2025. The record date is when Shelter Pharma identifies eligible shareholders for the dividend payment.

The annual dividend paid by Shelter Pharma varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Shelter Pharma's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.